Please login to view this media
- Talk
- UK
Waiting Lists for Symptomatic Joint Arthritis are Not Benign: Prioritizing Patients for Surgery in the Setting of COVID-19
Description
The presentation titled "Waiting lists for symptomatic joint arthritis are not benign" is led by James Morris, who examines the significant impact of COVID-19 on elective orthopedic services, particularly for patients awaiting surgery for joint arthritis. Morris highlights that the pandemic forced healthcare systems globally to prioritize acute care, leading to postponements of essential treatments for non-life-threatening conditions, such as arthritis.
During the presentation, Morris discusses a study that evaluated the health status and quality of life of patients whose outpatient appointments for joint assessments were canceled due to the pandemic. The study surveyed 210 patients, with a notable 79% reporting deterioration in their health and quality of life since their initial referrals, some even rating their health as "worse than death". This raises concerns about the unseen effects of waiting lists, which are often underestimated despite their severe implications for patients' well-being.
Morris emphasizes the need for healthcare systems to develop proper prioritization strategies for resuming elective surgeries, considering patients' quality of life and the potential harm from further delays. He reiterates that symptomatic joint arthritis significantly affects patients' lives, urging a more nuanced approach in managing scheduling and treatment prioritization. The study concludes that while these conditions might not present immediate life threats, their implications for health status and quality of life are critical and warrant immediate attention as healthcare systems adapt and recover.